BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter profit of $1.04 billion.
The Boston-based company said it had net income of $3.97 per share. Earnings, adjusted for one-time gains and costs, were $4.08 per share.
The results beat Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of $3.92 per share.
The drugmaker posted revenue of $2.48 billion in the period, which matched Street forecasts.
Vertex expects full-year revenue of $9.85 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX
